Advertisement

Topics

CTT Cancer Targeting Technologies Ltd Company Profile

22:56 EDT 22nd June 2018 | BioPortfolio

CTT Cancer Targeting Technologies is a biopharmaceutical company focusing on oncology and inflammatory diseases. The company possesses two core technologies: the phage-display technology and the peptide-liposome technology. The combination of these two will generate a steady flow of objects to be further developed into new drug delivery systems and diagnostic imaging tools. The company was founded in 2001 after CTT Cancer Targeting Technologies team had won the first prize in 2001 Venture Cup Finland contest, and the second place in the Munich Entrepreneurship Competition European Workshop MECEW 2001. In 2005, the company received an honorable mention as one of the most successful start-up companies rewarded in Venture Cup during 2000-2004.

Location

Viikinkaari 4C FIN-00790
Helsinki
Finland

Contact

Phone: 358 9 319 36388
Fax: 358 9 319 36398
Email: info@cancertargeting.com


News Articles [3250 Associated News Articles listed on BioPortfolio]

American Gene Technologies: the first bio-safe gene delivery vector for human clinical therapeutic use

In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with Jeff Galvin, Chief Executive Officer at American Gene Technologies, a genetic research firm focusing on gene therap...

Medical News Today: Cancer: Targeting protein may stop tumors from spreading

Researchers have now taken a major step in the prevention of cancer metastasis by identifying and targeting a protein that helps tumors to spread.

MABp1: 'Clever' New Antibody Targeting Colorectal Cancer

A trial using MABp1, an antibody targeting interleukin 1 alpha, showed some benefit for patients with advanced colorectal cancer, but Dr Kerr thinks the clinical endpoint used was a 'little soft.' M...

Cancer Treatment Targeting DNA Repair is Tested in Humans for the First Time

Onxeo has initiated a Phase I trial testing its first-in-class cancer treatment that works by inhibiting the repair of tumor DNA. Onxeo, a French biotech, has dosed its first patient in a Phase I stud...

Targeting Survivin May Open New Avenues for Immunotherapy

Antibody-mediated, immunotherapeutic strategies targeting survivin, a key cancer-related protein, may offer benefit in a variety of cancers.

Expert Discusses Bone-Targeting Agents in Prostate Cancer

Robert B. Den, MD, discusses bone-targeting agents in prostate cancer and the potential future of combinations.

Targeting Cilia Could Offer Universal Approach to Combat Anticancer Drug Resistance

Scientists in the U.K. have identified a potentially universal way to resensitize drug-resistant cancer cells to therapy, by targeting the cells’ cilia. The Institute of Cancer Research (ICR) team f...

Scientists discover how cancer-targeting 'Natural Killer' cells are fueled in the body

Scientists have just made an important discovery as to how cancer-targeting 'Natural Killer' cells are fueled in the body, which has significant implications for related therapies.

PubMed Articles [7446 Associated PubMed Articles listed on BioPortfolio]

Structure-based design for binding peptides in anti-cancer therapy.

The conventional anticancer therapeutics usually lack cancer specificity, leading to damage of normal tissues that patients find hard to tolerate. Ideally, anticancer therapeutics carrying payloads of...

Targeting de novo lipogenesis as a novel approach in anti-cancer therapy.

Although altered membrane physiology has been discussed within the context of cancer, targeting membrane characteristics by drugs being an attractive therapeutic strategy has received little attention...

Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth.

Glutamine (Gln) is essential for the proliferation of most cancer cells, making it an appealing target for cancer therapy. However, the role of Gln in gastric cancer (GC) metabolism is unknown and Gln...

Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer.

The clinical efficacy of therapies targeting the PD-1/PD-L1 pathway is still limited. In this issue of Cancer Cell, Li and colleagues identify a PD-L1 glycosylation-based mechanism in triple-negative...

New Opportunities and Challenges to Defeat Cancer Stem Cells.

Cancer stem cells (CSCs) are a subpopulation of cancer cells that are capable of self-renewal, proliferation, differentiation, plastic adaptation, and immune regulation, thereby mediating tumorigenesi...

Clinical Trials [8845 Associated Clinical Trials listed on BioPortfolio]

Effectiveness of Targeting Food Aid to Malnourished Children Compared to Targeting All Children Under Two Years

The objective of this study is to compare two approaches to targeting donated supplementary food to young children. The study compares the effectiveness of the widely-used curative approac...

CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies

CD19 expression on B cell frequently lost after CD19-targeting CAR-T therapy. In present study, we construct a CD22-targeting chimeric antigen receptor to overcome this issue.

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Collect Breast Cancer Patients' Digital Mammography Images With Corresponding Reports for the Development of Software

The purpose of this case collection effort is software design by R2 Technologies, Inc., The information received from Women's Imaging will be provided to the Case Collection, Data Manageme...

Companies [3059 Associated Companies listed on BioPortfolio]

CTT Cancer Targeting Technologies Ltd

CTT Cancer Targeting Technologies is a biopharmaceutical company focusing on oncology and inflammatory diseases. The company possesses two core technologies: the phage-display technology and the pepti...

Molecular Targeting Technologies, Inc.

Molecular Targeting Technologies, Inc. (MTTI) is a privately held US based Biotechnology Company founded to develop novel medical imaging products for the diagnosis of cardiovascu...

Curis, Inc.

Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidate...

AVAX Technologies Inc.

AVAX Technologies is a development stage biopharmaceutical company which is acquiring and developing technologies and products for the treatment of cancer and other life-threatening diseases. The Comp...

Techniclone International Corporation

TECHNICLONE CORPORATION is engaged in the research and development of unique therapeutics for the treatment of cancer: The company utilizes innovative targeting technologies to develop products capabl...

More Information about "CTT Cancer Targeting Technologies Ltd" on BioPortfolio

We have published hundreds of CTT Cancer Targeting Technologies Ltd news stories on BioPortfolio along with dozens of CTT Cancer Targeting Technologies Ltd Clinical Trials and PubMed Articles about CTT Cancer Targeting Technologies Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CTT Cancer Targeting Technologies Ltd Companies in our database. You can also find out about relevant CTT Cancer Targeting Technologies Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record